* CareDx Inc CDNA.OQ CDNA.O is expected to show a fall
in
quarterly revenue when it reports results on May 9 for the
period ending March 31 2024
* The Brisbane California California-based company is
expected to
report a 18.3% decrease in revenue to $63.14 million from $77.26
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data.
* LSEG's mean analyst estimate for CareDx Inc is for a loss
of 21
cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for CareDx Inc
is
$13.00, above its last closing price of $10.48.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Dec. 31 2023 -0.27 -0.27 -0.17 Beat 36.2
Sep. 30 2023 -0.40 -0.40 -0.18 Beat 54.5
Jan. 1 0001 -0.34 -0.31 -0.18 Beat 41.9
Mar. 31 2023 -0.10 -0.11 -0.11 Met -1.9
Dec. -0.08 -0.09 -0.07 Beat 18.8
31 2022
Sep. 30 2022 -0.14 -0.14 -0.06 Beat 57.1
Jun. 30 2022 -0.11 -0.11 -0.13 Missed -16.1
Mar. 31 2022 -0.05 -0.05 -0.13 Missed -160
This summary was machine generated May 8 at 00:29 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)